Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B ‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis
ConclusionOverall, blinatumomab was beneficial as first salvage and as second or later salvage, but the effects were favorable as first salvage.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Max S. Topp,
Anthony S. Stein,
Nicola G ökbuget,
Heinz‐August Horst,
Nicolas Boissel,
Giovanni Martinelli,
Hagop Kantarjian,
Monika Brüggemann,
Yuqi Chen,
Gerhard Zugmaier Tags: ORIGINAL RESEARCH Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Leukemia | Stem Cell Therapy | Stem Cells | Study | Transplants